forecast

mRNA platforms allow de-risking before clinical entry

mRNA technology is a powerful platform because developers can rapidly prototype candidates and reduce risk before entering clinical trials, although trials still take time.

forecastpending

Speaker

Mark Smith

Evidence Quote

“knowing what you want to target and being able to heavily de-risk that before you get into the clinic is a really interesting technological platform.”

Source

Finch Therapeutics: Empowering Immune Systems— Business Breakdowns
Created: 11/16/2026, 7:13:42 PM

Your notes

Loading notes...